Onconova Therapeutics Company Profile (NASDAQ:ONTX)

About Onconova Therapeutics (NASDAQ:ONTX)

Onconova Therapeutics logoOnconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ONTX
  • CUSIP: N/A
  • Web: www.onconova.com
Capitalization:
  • Market Cap: $13.27 million
  • Outstanding Shares: 6,772,000
Average Prices:
  • 50 Day Moving Avg: $2.25
  • 200 Day Moving Avg: $2.61
  • 52 Week Range: $1.85 - $8.17
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.84
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $5.55 million
  • Price / Sales: 2.39
  • Book Value: $0.64 per share
  • Price / Book: 3.06
Profitability:
  • EBIDTA: ($20,610,000.00)
  • Net Margins: -73.67%
  • Return on Equity: -148.52%
  • Return on Assets: -50.49%
Debt:
  • Current Ratio: 3.10%
  • Quick Ratio: 3.10%
Misc:
  • Average Volume: 184,124 shs.
  • Beta: 0.07
  • Short Ratio: 1.14
 

Frequently Asked Questions for Onconova Therapeutics (NASDAQ:ONTX)

What is Onconova Therapeutics' stock symbol?

Onconova Therapeutics trades on the NASDAQ under the ticker symbol "ONTX."

When did Onconova Therapeutics' stock split? How did Onconova Therapeutics' stock split work?

Shares of Onconova Therapeutics reverse split on the morning of Tuesday, May 31st 2016. The 1-10 reverse split was announced on Friday, May 20th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 30th 2016. An investor that had 100 shares of Onconova Therapeutics stock prior to the reverse split would have 10 shares after the split.

How were Onconova Therapeutics' earnings last quarter?

Onconova Therapeutics Inc (NASDAQ:ONTX) posted its earnings results on Monday, May, 15th. The company reported ($1.23) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.96) by $0.27. The firm had revenue of $0.21 million for the quarter. Onconova Therapeutics had a negative net margin of 73.67% and a negative return on equity of 148.52%. View Onconova Therapeutics' Earnings History.

Where is Onconova Therapeutics' stock going? Where will Onconova Therapeutics' stock price be in 2017?

2 brokerages have issued 1 year target prices for Onconova Therapeutics' stock. Their forecasts range from $6.00 to $10.00. On average, they anticipate Onconova Therapeutics' share price to reach $8.00 in the next twelve months. View Analyst Ratings for Onconova Therapeutics.

Who are some of Onconova Therapeutics' key competitors?

Who owns Onconova Therapeutics stock?

Onconova Therapeutics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Tyndall Capital Partners L P (7.69%), Sabby Management LLC (5.68%), Boxer Capital LLC (4.67%), Renaissance Technologies LLC (1.79%) and Vanguard Group Inc. (0.82%). Company insiders that own Onconova Therapeutics stock include E Premkumar Reddy, Mark Patrick Guerin and Ramesh Kumar. View Institutional Ownership Trends for Onconova Therapeutics.

Who sold Onconova Therapeutics stock? Who is selling Onconova Therapeutics stock?

Onconova Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including Sabby Management LLC and Renaissance Technologies LLC. View Insider Buying and Selling for Onconova Therapeutics.

Who bought Onconova Therapeutics stock? Who is buying Onconova Therapeutics stock?

Onconova Therapeutics' stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and Boxer Capital LLC. Company insiders that have bought Onconova Therapeutics stock in the last two years include E Premkumar Reddy, Mark Patrick Guerin and Ramesh Kumar. View Insider Buying and Selling for Onconova Therapeutics.

How do I buy Onconova Therapeutics stock?

Shares of Onconova Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Onconova Therapeutics stock cost?

One share of Onconova Therapeutics stock can currently be purchased for approximately $1.96.

Analyst Ratings

Consensus Ratings for Onconova Therapeutics (NASDAQ:ONTX) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (308.16% upside)

Analysts' Ratings History for Onconova Therapeutics (NASDAQ:ONTX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017Maxim GroupSet Price TargetBuy$6.00LowView Rating Details
4/27/2017LaidlawInitiated CoverageBuy -> Buy$10.00LowView Rating Details
3/29/2016HC WainwrightReiterated RatingBuyN/AView Rating Details
12/9/2015Piper Jaffray CompaniesReiterated RatingOverweight$60.00N/AView Rating Details
8/28/2015Janney Montgomery ScottReiterated RatingNeutral -> Fair Value$30.00 -> $15.20N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Onconova Therapeutics (NASDAQ:ONTX)
Earnings by Quarter for Onconova Therapeutics (NASDAQ:ONTX)
Earnings History by Quarter for Onconova Therapeutics (NASDAQ:ONTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q1 2017($0.96)($1.23)$0.21 millionViewN/AView Earnings Details
11/14/2016Q3 2016($0.82)($0.29)$1.60 million$1.70 millionViewN/AView Earnings Details
8/15/2016Q2($1.96)$2.25 millionViewN/AView Earnings Details
5/11/2016Q1($0.19)($0.27)$1.34 million$1.47 millionViewN/AView Earnings Details
3/28/2016Q4($0.27)$0.18$9.60 millionViewN/AView Earnings Details
11/11/2015Q3($0.32)($0.26)$0.11 million$1.62 millionViewN/AView Earnings Details
8/13/2015Q2($0.56)($0.41)$0.11 million$0.12 millionViewN/AView Earnings Details
5/14/2015Q1($0.63)($0.57)$0.11 million$0.11 millionViewN/AView Earnings Details
3/26/2015($0.71)($0.62)$0.11 millionViewN/AView Earnings Details
11/13/2014($0.78)($0.69)$0.11 millionViewN/AView Earnings Details
8/13/2014($0.89)($0.77)$0.56 million$0.13 millionViewN/AView Earnings Details
5/12/2014($0.78)($0.87)$1.32 million$0.45 millionViewN/AView Earnings Details
3/10/2014Q4 13($1.07)($0.68)$1.07 million$1.93 millionViewN/AView Earnings Details
11/12/2013Q3($0.66)($1.34)$1.07 million$1.12 millionViewListenView Earnings Details
9/6/2013Q213($5.21)$0.22 million$0.59 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Onconova Therapeutics (NASDAQ:ONTX)
Current Year EPS Consensus Estimate: $-3.30 EPS
Next Year EPS Consensus Estimate: $-2.33 EPS

Dividends

Dividend History for Onconova Therapeutics (NASDAQ:ONTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Onconova Therapeutics (NASDAQ:ONTX)
Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 20.59%
Insider Trades by Quarter for Onconova Therapeutics (NASDAQ:ONTX)
Institutional Ownership by Quarter for Onconova Therapeutics (NASDAQ:ONTX)
Insider Trades by Quarter for Onconova Therapeutics (NASDAQ:ONTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/26/2017E Premkumar ReddyDirectorBuy119,048$2.10$250,000.80View SEC Filing  
4/26/2017Mark Patrick GuerinCFOBuy1,429$2.10$3,000.90View SEC Filing  
4/26/2017Ramesh KumarInsiderBuy23,810$2.10$50,001.00View SEC Filing  
2/21/2014& Jane Hoffman 2013 De Michaelmajor shareholderBuy143,480$8.47$1,215,275.60View SEC Filing  
2/10/2014Ramesh KumarCEOSell33,543$15.07$505,493.01View SEC Filing  
2/3/2014Ramesh KumarCEOSell60,000$15.05$903,000.00View SEC Filing  
1/27/2014Michael HoffmanDirectorBuy57,295$11.92$682,956.40View SEC Filing  
11/22/2013Michael HoffmanDirectorBuy5,000$14.39$71,950.00View SEC Filing  
11/18/2013E Premkumar ReddyDirectorBuy5,000$12.10$60,500.00View SEC Filing  
11/15/2013& Jane Hoffman 2013 De Michaelmajor shareholderBuy19,700$11.99$236,203.00View SEC Filing  
11/15/2013Henry BienenDirectorBuy1,400$12.17$17,038.00View SEC Filing  
11/15/2013Ramesh KumarCEOBuy1,100$12.02$13,222.00View SEC Filing  
7/30/2013& Jane Hoffman 2013 De MichaelMajor ShareholderBuy1,000,000$15.00$15,000,000.00View SEC Filing  
7/30/2013Ramesh KumarCEOBuy6,667$15.00$100,005.00View SEC Filing  
7/30/2013Thomas J MckearnInsiderBuy3,333$15.00$49,995.00View SEC Filing  
7/30/2013Viren MehtaDirectorBuy16,667$15.00$250,005.00View SEC Filing  
7/25/2013E Premkumar ReddyDirectorBuy1,000$22.72$22,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Onconova Therapeutics (NASDAQ:ONTX)
Latest Headlines for Onconova Therapeutics (NASDAQ:ONTX)
Source:
DateHeadline
americanbankingnews.com logoZacks: Onconova Therapeutics Inc (ONTX) Given Average Recommendation of "" by Analysts
www.americanbankingnews.com - May 24 at 4:10 PM
finance.yahoo.com logoOnconova Announces Multiple Presentations at the 22nd Congress of the European Hematology Association
finance.yahoo.com - May 22 at 9:45 AM
finance.yahoo.com logoOnconova Therapeutics to Present a Poster Session Relating to Intravenous Rigosertib at the 2017 American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 19 at 11:49 AM
finance.yahoo.com logoEdited Transcript of ONTX earnings conference call or presentation 15-May-17 1:00pm GMT
finance.yahoo.com - May 16 at 6:46 PM
americanbankingnews.com logoOnconova Therapeutics Inc (ONTX) Releases Quarterly Earnings Results, Misses Expectations By $0.27 EPS
www.americanbankingnews.com - May 16 at 6:14 PM
americanbankingnews.com logoOnconova Therapeutics Inc (ONTX) PT Set at $6.00 by Maxim Group
www.americanbankingnews.com - May 15 at 3:14 PM
finance.yahoo.com logoInvestor Network: Onconova Therapeutics Inc. to Host Earnings Call
finance.yahoo.com - May 15 at 9:59 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2017 Financial Results
finance.yahoo.com - May 15 at 9:59 AM
nasdaq.com logoOnconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results - Nasdaq
www.nasdaq.com - May 5 at 7:19 PM
americanbankingnews.com logo Onconova Therapeutics Inc (ONTX) Given Average Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - May 5 at 2:28 PM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results
finance.yahoo.com - May 4 at 7:13 PM
americanbankingnews.com logoOnconova Therapeutics (ONTX) Given Daily Media Sentiment Score of 0.17
www.americanbankingnews.com - May 4 at 11:17 AM
finance.yahoo.com logoOnconova to Present Rigosertib Clinical Data at the 14th International Symposium on Myelodysplastic Syndromes - Yahoo Finance
finance.yahoo.com - May 1 at 12:04 PM
finance.yahoo.com logoOnconova to Present Rigosertib Clinical Data at the 14th International Symposium on Myelodysplastic Syndromes
finance.yahoo.com - May 1 at 12:04 PM
bizjournals.com logoBucks County biopharm firm closes $5.2M stock sale
www.bizjournals.com - April 29 at 7:28 PM
americanbankingnews.com logoRamesh Kumar Acquires 23,810 Shares of Onconova Therapeutics Inc (ONTX) Stock
www.americanbankingnews.com - April 28 at 7:28 PM
americanbankingnews.com logoE Premkumar Reddy Purchases 119,048 Shares of Onconova Therapeutics Inc (ONTX) Stock
www.americanbankingnews.com - April 28 at 7:27 PM
americanbankingnews.com logoLaidlaw Initiates Coverage on Onconova Therapeutics Inc (ONTX)
www.americanbankingnews.com - April 27 at 10:12 PM
globenewswire.com logoOnconova Therapeutics Announces Closing of Public Offering of Common Stock - GlobeNewswire (press release)
globenewswire.com - April 27 at 7:30 PM
americanbankingnews.com logoOnconova Therapeutics (ONTX) Earning Somewhat Negative Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 27 at 5:04 PM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC
finance.yahoo.com - April 26 at 6:14 PM
finance.yahoo.com logoOnconova Therapeutics Announces Closing of Public Offering of Common Stock
finance.yahoo.com - April 26 at 6:14 PM
americanbankingnews.com logoOnconova Therapeutics (ONTX) Receiving Very Favorable Press Coverage, Report Finds
www.americanbankingnews.com - April 24 at 9:34 AM
streetinsider.com logoOnconova Therapeutics (ONTX) Plans Offering of Common Stock
www.streetinsider.com - April 22 at 12:28 PM
finance.yahoo.com logoOnconova Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - April 21 at 6:54 PM
finance.yahoo.com logoOnconova Therapeutics stock drops 12% after pricing stock offering
finance.yahoo.com - April 21 at 6:54 PM
americanbankingnews.com logoOnconova Therapeutics Inc (ONTX) Short Interest Update
www.americanbankingnews.com - April 21 at 11:00 AM
finance.yahoo.com logoOnconova Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 21 at 12:09 AM
americanbankingnews.com logoOnconova Therapeutics (ONTX) Getting Very Positive Press Coverage, Report Finds
www.americanbankingnews.com - April 20 at 1:05 PM
americanbankingnews.com logo Onconova Therapeutics Inc (ONTX) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - April 20 at 11:19 AM
americanbankingnews.com logoOnconova Therapeutics (ONTX) Receives Daily Coverage Optimism Rating of 0.56
www.americanbankingnews.com - April 17 at 12:46 PM
finance.yahoo.com logoOnconova Therapeutics and Pluristem Therapeutics Surge as Candidate Drugs Move Closer to Final Approval
finance.yahoo.com - April 7 at 11:43 AM
americanbankingnews.com logo Analysts Set $5.50 Target Price for Onconova Therapeutics Inc (ONTX)
www.americanbankingnews.com - April 5 at 6:30 PM
americanbankingnews.com logoMaxim Group Analysts Give Onconova Therapeutics Inc (ONTX) a $6.00 Price Target
www.americanbankingnews.com - March 31 at 12:20 PM
biz.yahoo.com logoONCONOVA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 29 at 7:44 PM
finance.yahoo.com logoEdited Transcript of ONTX earnings conference call or presentation 27-Mar-17 1:00pm GMT
finance.yahoo.com - March 28 at 9:56 AM
baystreet.ca logoOnconova Therapeutics (ONTX) Falls as Earnings Readied
www.baystreet.ca - March 27 at 6:31 PM
americanbankingnews.com logoOnconova Therapeutics Inc (ONTX) Given a $6.00 Price Target at Maxim Group
www.americanbankingnews.com - March 27 at 3:25 PM
finance.yahoo.com logoOnconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results
finance.yahoo.com - March 27 at 9:55 AM
biz.yahoo.com logoQ4 2016 Onconova Therapeutics Inc Earnings Release - Before Market Open
biz.yahoo.com - March 27 at 9:55 AM
biz.yahoo.com logoONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
biz.yahoo.com - March 27 at 9:55 AM
americanbankingnews.com logoOnconova Therapeutics Inc (ONTX) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - March 24 at 9:28 PM
globenewswire.com logoOnconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences - GlobeNewswire (press release)
globenewswire.com - March 24 at 12:33 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences
finance.yahoo.com - March 21 at 11:14 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results
finance.yahoo.com - March 16 at 8:47 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Present at Two Healthcare Conferences in March
finance.yahoo.com - March 2 at 8:51 AM
globenewswire.com logoOnconova Therapeutics, Inc. to Present at Two Investor Conferences in February - GlobeNewswire (press release)
globenewswire.com - February 10 at 1:10 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. to Present at Two Investor Conferences in February
finance.yahoo.com - February 9 at 8:08 PM
feeds.benzinga.com logoOnconova Therapeutics, Inc. to Present at NobleCON13
feeds.benzinga.com - January 27 at 9:34 AM
finance.yahoo.com logoSeeThruEquity Initiates Coverage on Onconova Therapeutics, Inc. (NASDAQ: ONTX) with a Price Target of $5.00
finance.yahoo.com - January 12 at 7:40 PM

Social

Chart

Onconova Therapeutics (ONTX) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff